Sign in

CIK 0001360214

  • Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450567010
Phone
+1 615-733-4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
  1. 4 Open-market buy Director bought 25,000 shares at $13.37 ($334,250)
  2. 4 Open-market buy Director bought 1,860 shares at $13.42 ($24,961)
  3. 4 Open-market buy 10% owner bought 431,183 shares at $10.52 ($4,536,045)
  4. 4 Open-market sale Director sold 40,000 shares at $12.62 ($504,800)
  5. 4 Open-market buy 10% owner bought 11,085 shares at $9.77 ($108,354)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy 10% owner bought 41,389 shares at an average $6.75 ($279,502)
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 4 Shares withheld for taxes Chief Financial Officer gave up 20,605 shares (to pay taxes)
  15. 4 Shares withheld for taxes President, ImprimisRx gave up 25,923 shares (to pay taxes)
  16. 4 Open-market buy 10% owner bought 6,343 shares at $6.89 ($43,686)
  17. 4 Shares withheld for taxes Chief Executive Officer gave up 71,406 shares (to pay taxes)
  18. 4 Open-market sale Director sold 3,900 shares at $10.04 ($39,156)
  19. 4 Open-market sale Director sold 20,000 shares at an average $9.07 ($181,391)
  20. 4 Open-market buy 10% owner bought 52,500 shares at $8.45 ($443,363)

Page 5 of 15 · 296 filings